Recent Articles from GlobeNewswire

NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Planet Fitness, Inc. (“Planet Fitness” or the “Company”) (NYSE: PLNT) on behalf of investors that purchased or otherwise acquired Planet Fitness securities between November 6, 2025 and May 6, 2026 (the “Class Period”).

Industry leader to advance CRB’s growth strategy as life sciences manufacturers face rising complexity, capital pressure and speed-to-market decisions

Directive’s expansion reflects growing B2B demand to move upstream into brand and communications to influence demand

Signed agreements cover a historic U.S. tantalum asset and existing processing infrastructure with a district-scale lithium-cesium-tantalum exploration position

AUSTIN, Texas, Sept. 09, 2026 (GLOBE NEWSWIRE) -- SailPoint, Inc. (Nasdaq: SAIL), a leader in enterprise identity security, today announced financial results for its fiscal second quarter ended July 31, 2026.

Patient Experienced Resolution of Ascites, Regression of Esophageal Varices and Remained Clinically Stable for Approximately 28 Months Prior to Successful Liver Transplantation

Firm Earns Repeat Recognition for Crypto Innovation and Options Strategy Leadership

Enrollment in LUMINA, the pivotal Phase 2 study of obe-cel in refractory lupus nephritis, is ongoing

NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced Copper Giant Resources Corp. (TSX-V: CGNT; OTCQX: CGNRF), a mineral exploration company, has qualified to trade on the OTCQX® Best Market. Copper Giant Resources Corp. upgraded to OTCQX from the OTCQB® Venture Market.

Sales of $111.6 million, Net Income of $0.04 per diluted share, Adjusted Net Income of $0.05 per diluted share 

LOUISVILLE, Ky., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected by Takeda Pharmaceuticals as an ultra-narrow limited distribution partner for MIMRYLO™ (rusfertide), which is indicated for the treatment of erythrocytosis in adults with polycythemia vera (PV).1

SCOTTSDALE, Ariz., Sept. 09, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (“LifeStance” or the “Company”) (Nasdaq: LFST), one of the nation’s largest providers of virtual and in-person outpatient mental health care, today announced that pursuant to a shelf registration statement filed with the Securities and Exchange Commission (the “SEC”), certain stockholders of the Company (the “Selling Stockholders”) intend to offer 22,250,000 shares of LifeStance’s common stock, par value $0.01 per share (the “Common Stock”). The Selling Stockholders will receive all of the proceeds from the offering. The Company is not selling any shares of Common Stock in the offering and will not receive any proceeds from the offering.

JERSEY, Channel Islands — September 9, 2026 — CoinShares PLC (Nasdaq: CSHR) ("CoinShares" or the "Company"), a leading global asset manager specializing in digital assets, today announced that President and Chief Executive Officer Jean-Marie Mognetti will attend the Oppenheimer Fintech Leaders Conference in New York, taking place September 15, 2026.

Approximately 95,000 engineering hours and market validation of ~90% of pricing underpin AACE Class 3 estimate accuracy across the full Project scope

Celebrating six seasons as a proud whiskey partner of the Denver Broncos, Breckenridge Distillery debuts a limited-edition Bourbon Whiskey lineup and Creamsicle Whiskey Seltzer built for Broncos Country, game-day traditions, and one of football’s most iconic moments

TORONTO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Xanadu Quantum Technologies Limited ("Xanadu"; NASDAQ/TSX: XNDU), a leading photonic quantum computing company, and ASML, a leading supplier to the semiconductor industry, today announced a collaboration to develop advanced lithography processes for Xanadu’s photonic quantum hardware. This collaboration aims to enable both companies to gain deeper insight into how advanced lithography innovations can help reduce optical losses in quantum computing chips, accelerating the industry's path toward utility-scale quantum computing (USQC).

SAN FRANCISCO and BOSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- MapLight Therapeutics, Inc. (Nasdaq: MPLT) today announced that members of its management team will participate in the following investor conference:

MICVO demonstrated rapid and deep responses, with a 36% confirmed objective response rate (cORR) and 94% disease control rate (DCR), with clinical activity observed across HPV status and prior-treatment subgroups

MONTVALE, N.J., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the 9th Annual Wells Fargo Consumer Conference on September 23, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.

Strategic investment will support continued advancement of the Accumulus platform and expand global adoption across the life sciences regulatory ecosystem

BURLINGTON, Mass., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Fractyl Health, Inc. (Nasdaq: GUTS) (the Company or Fractyl), a clinical stage metabolic therapeutics company focused on pioneering novel approaches to treat obesity and type 2 diabetes (T2D), today announced that Harith Rajagopalan, M.D., Ph.D., Co-Founder and Chief Executive Officer of the Company, will be participating in the following upcoming investor conferences:

IRVINE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation highlighting the long-term safety and efficacy of tegoprubart in preventing kidney transplant rejection will take place at the upcoming International Congress of The Transplantation Society in Sydney, Australia, from September 20–23, 2026.

Connected Agentic Ecosystem Accelerates Revenue Growth For Media Companies In The Agentic Workflow Era

Company to engage with the global ophthalmology and investment community as it advances urcosimod through its global Phase 3 pivotal trial for neuropathic corneal pain

Accomplished Industry Executive to Lead Commercial Strategy and Launch Readiness

SAN DIEGO, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a transformative pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced clinical data from its off-the-shelf anti-CD19 CAR T-cell product candidate FT819, and pre-clinical data from its off-the-shelf anti-CD19 and CD38 CAR T-cell product candidate FT839 will be featured at the Congress of Clinical Rheumatology West (CCR – West) meeting, being held in Huntington Beach, CA on September 17-20, 2026.

Data from the Phase 3 sunRIZE study remains under review by FDA 

As the Birthday Capital of the Universe, Chuck E. Cheese reveals that kids hold real influence over their birthday celebrations and value activities over themes and decorations

– Study met its primary endpoint, with afimetoran demonstrating higher SRI-4 response rates versus placebo at Week 48 (p-value <0.001 across all dose groups) –

Letter to shareholders covers Austin ProtoHub results, CTF Solar manufacturing, Honda R&D efficiency work, and Sparc Hydrogen collaboration

Porustobart, a second-generation Fc-enhanced CTLA-4 antibody, is being advanced across two clinical indications in the neoadjuvant setting, beginning with MSS clinical stage II-III colon cancer

NEW YORK, Sept. 09, 2026 (GLOBE NEWSWIRE) -- ODDITY Tech Ltd. (NASDAQ: ODD) today announced its financial results for the second quarter ended June 30, 2026.

ASHA Joins National Effort To “Make Vestibular Visible” for September Awareness Week

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Sept. 09, 2026 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a biopharmaceutical company focused on developing innovative, patient-centric therapies for chronic diseases, and Rose Pharma Inc. (Rose Pharma) today announced that they have entered into a worldwide licensing and collaboration agreement to develop ROSE-010 Technosphere for weight management. ROSE-010 is an investigational, rapid-acting glucagon-like peptide-1 (GLP-1) receptor agonist that will be formulated using MannKind’s proprietary Technosphere dry-powder inhalation technology. The companies intend to evaluate whether a rapid-acting, short-duration inhaled GLP-1 may offer a flexible approach to weight management.

MELBOURNE, Australia and INDIANAPOLIS, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) advises that Dr. Christian Behrenbruch, Managing Director and Group CEO and Kevin Richardson, CEO, Precision Medicine will present at the upcoming Morgan Stanley 24th Annual Global Healthcare Conference and at the H.C. Wainwright 28th Annual Global Investment Conference, both in New York, NY.

Standing offer establishes a streamlined pathway for Government of Canada to acquire EarthDaily commercial satellite imagery products.

Existing collaboration in energy and next-generation batteries expands toward capital participation, further strengthening ProLogium's long-term engagement with Japan's industrial ecosystem

HOUSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE:SYY) (“Sysco” or the “Company”) is reaffirming its fiscal 2027 financial guidance (originally issued on August 4, 2026) ahead of the Company’s webcast presentation from the Barclays 19th Annual Global Consumer Staples Conference in Boston scheduled for today, Wednesday, September 9, at 12:00 p.m. ET. The live conference webcast can be accessed at investors.sysco.com.

Family owned, Certified B Corporation tea company's flagship charity race unites runners, walkers and volunteers to support 21 Connecticut nonprofits

Completion of USACE Public Comment Stage Marks Key Step in Federal Review as State and Environmental Workstreams Progress

The Weather Network’s 2026 Fall Forecast

FreedomPay’s autonomous commerce platform delivers AI-ready reconciliation and analytics

HOUSTON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- KBR (NYSE: KBR) announced that its Mission Technology Solutions business, which will become Trinzic following its planned spin-off, has won a three-year contract to continue advancing mission-critical radio frequency engineering and modernization for a U.S. government customer. The award supports the continuity and readiness of essential national security systems. It reinforces KBR’s strategic position as a trusted technology partner, combining deep mission expertise with an outcome-driven approach and rapid execution.

New report introduces the “AI Sovereignty Paradox,” arguing that long-term AI advantage depends on maintaining strategic control and choice while participating in global AI ecosystems.

Reception of the First Two Falcon Albatros Aircraft by the DGA

Basel, Switzerland and Chassieu, France, , Sept. 09, 2026 (GLOBE NEWSWIRE) --

BERLIN, Sept. 09, 2026 (GLOBE NEWSWIRE) -- PetSuper, a smart pet technology brand focused on developing intelligent products that enhance everyday pet care, made its debut at IFA 2026. Showcasing its connected smart pet portfolio and its evolving vision for an AI-powered smart pet ecosystem, the brand demonstrated how smart hardware, IoT connectivity, everyday care data and PetSuperAi can work together to support more connected and informed pet care.

- Treatment with oral infigratinib for 52 weeks in PROPEL 3 resulted in favorable trends against placebo in clinically meaningful exploratory endpoints including sleep apnea and otitis media events

Hands-on trials of the Q3 Air Pro highlighted TORRAS's push to expand phone cases beyond protection into viewing, navigation and filming

BERLIN, Sept. 09, 2026 (GLOBE NEWSWIRE) -- At IFA 2026, KAXFREE showcased a smart home coffee portfolio shaped by KALERM Group’s 16 years of commercial coffee-machine experience. At Hall 8.1, Booth 224, demonstrations and tastings highlighted its adaptation for home use.

New building will accelerate pilot-line capabilities and customer engagement while reducing facility overhead from 30% to 10% of monthly operating expenses

Unifying exposure management and SOC workflows with Zscaler telemetry and specialized AI agents that detect, investigate, and respond to threats at machine speed

New research finds 54% say vendor lock-in makes it difficult to adapt to changing regulatory requirements as cloud costs, AI workloads, and infrastructure complexity rise

LONDON, Sept. 09, 2026 (GLOBE NEWSWIRE) -- StoneX Group Inc. (NASDAQ: SNEX) today announced that City Index, one of UK’s most established trading brands, is relaunching as StoneX Trading.

RESTON, Va., Sept. 09, 2026 (GLOBE NEWSWIRE) -- 82% of organizations have been asked to document or explain an identity-related decision to a regulator, court, or external auditor, according to a global study by Regula of 850 fraud prevention and financial crime decision-makers. Among that group, 32% could provide only limited or indirect evidence, making it harder to defend decisions, investigate fraud, resolve disputes, and demonstrate compliance.

KOBE, Japan, Sept. 09, 2026 (GLOBE NEWSWIRE) -- Micware Co., Ltd. (Nasdaq: MWC) (the “Company” or “Micware”), a Japan-based provider of software development services and innovative IT solutions mainly focused on the automotive and mobility sectors, today announced the signing of a Memorandum of Understanding (“MOU”) with MulticoreWare, Inc. (“MultiCoreWare”) to explore potential collaboration on next-generation artificial intelligence (“AI”) solutions, with a focus on advanced driver assistance systems (“ADAS”) performance optimization and integration, AI-powered in-vehicle user experience, and physical AI at the edge.

Liege, Belgium – 9 September 2026 (08:30 CET) – Allegro NV, a biomedical company developing a transformative nanotechnology treatment for osteoarthritis, today announced statistically significant improvements in pain and function endpoints over 6-months from an ongoing clinical study with Hydrocelin in 30 patients with knee osteoarthritis.

Cimplifi, a leader in AI orchestration for eDiscovery and contract analytics, today announced that Cheza Ross has joined the company as director, business development, further strengthening the commitment of Cimplifi to serving clients across the United Kingdom and Europe

With 65,000 runners expected to descend on Copenhagen for the World Athletics Road Running Championships, restaurants across the city are serving customised carb-loaded dishes to help athletes prepare for race day.

OM System’s latest entry in the PEN Mirrorless Camera series is a compact, intuitive camera designed for everyday and travel photography

Lille (France), Cambridge (Massachusetts, United States), September 9, 2026 - GENFIT (Euronext: GNFT), a biopharmaceutical company dedicated to improving the lives of patients with rare and life-threatening liver diseases, today highlights the long-term commercial opportunity associated with NIS4® and next-generation NIS2+®, its proprietary non-invasive NISTM diagnostic technologies aimed to identify patients with “at-risk MASH”.

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE 7(1) OF THE EUROPEAN MARKET ABUSE REGULATION (596/2014)

VALLOUREC AND ARAMCO STRENGTHEN THEIR PARTNERSHIP THROUGH THE SIGNING OF AN AGREEMENT FOR THE SUPPLY OF OIL COUNTRY TUBULAR GOODS

Bright Dairy

SINGAPORE and HONG KONG, Sept. 09, 2026 (GLOBE NEWSWIRE) -- OSL Group (HKEX:863) (OSL), a global stablecoin payment and trading platform, today announced a partnership with Waka, a payments platform connecting emerging-market liquidity with global settlement. Under the collaboration, OSL's institutional stablecoin infrastructure — providing stablecoin-to-USD fiat conversion and USD payout — is now integrated into Waka's settlement infrastructure serving Africa–global trade corridors.

NEW YORK CITY and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in York Space Systems, Inc. (“York Space Systems” or the “Company”) (NYSE: YSS) of a class action securities lawsuit.

NEW YORK  and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until September 22, 2026 to file lead plaintiff applications in a securities class action lawsuit against PROCEPT BioRobotics Corporation ("Procept" or the "Company") (NasdaqGM: PRCT), if they purchased the Company’s shares between February 28, 2024 and February 25, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Northern District of California.

NEW YORK and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Capricor Therapeutics, Inc. (“Capricor” or the “Company”) (NasdaqGS: CAPR) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Avis Budget Group, Inc. (“Avis” or the “Company”) (NasdaqGS: CAR) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Wix.com Ltd. (“Wix” or the “Company”) (NasdaqGS: WIX) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until October 13, 2026 to file lead plaintiff applications in a securities class action lawsuit against Simply Good Foods Company (“Simply Good” or the “Company”) (NasdaqCM: SMPL), if they purchased or otherwise acquired the Company’s shares between October 24, 2024 and April 8, 2026, inclusive (the “Class Period”). This action is pending in the United States District Court for the Southern District of New York.

NEW YORK CITY and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in EquipmentShare.com Inc. (“EquipmentShare” or the “Company”) (NasdaqGS: EQPT) of a class action securities lawsuit.

NEW YORK and NEW ORLEANS, Sept. 08, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in Primoris Services Corporation (“Primoris” or the “Company”) (NYSE: PRIM) of a class action securities lawsuit.